Hyperbaric Oxygen for Fibromyalgia: Is It Worth the Cost?
Hyperbaric oxygen therapy means breathing oxygen in a pressurised chamber. Earlier trials suggested it may help people with fibromyalgia. A new analysis from Brazil asks a different question: does the benefit justify the cost? The study appeared in BMJ Open on October 22, 2026.
The Study
The analysis used data from a randomised trial at the rheumatology department of the Federal University of Juiz de Fora. It included 56 women aged 18 to 70 with fibromyalgia under the 2016 ACR criteria.
- All women received standard clinical care.
- Therapy: 32 to 40 sessions in a pressure chamber at 2.3 atmospheres, 90 minutes per session, five sessions a week.
- One group started in weeks 0 to 8. The other started in weeks 8 to 16, so the two groups could be compared.
The researchers compared costs with quality-adjusted life years (QALYs), a measure that combines length of life and quality of life.
The Results
- At 8 weeks: the therapy group had higher costs (US$2,478 against US$1,068 for standard care alone) and a higher quality-of-life score (0.630 against 0.477).
- At 16 weeks: costs were US$3,546 against US$2,137. The quality-of-life score was 0.642 against 0.477.
- Cost per QALY gained: about US$9,210 at 8 weeks and US$8,540 at 16 weeks.
- Both figures fell below the Brazilian threshold of US$9,315 per QALY. At 8 weeks it was only just below.
In short, the therapy cost more than standard care alone, and it met the threshold Brazil uses to judge whether a treatment is good value.
Limits of the Study
- The group was small, and all participants were women at one centre.
- The quality-of-life values were estimated from a questionnaire (SF-12), not measured directly.
- The model covers only four months. It does not show whether the effect lasts.
- The result depends on Brazilian prices and the Brazilian threshold. It does not apply directly to other countries.
- The authors call for larger, multi-centre studies with longer follow-up.
What This Means for You
This study does not prove that hyperbaric oxygen is a good choice for everyone. It shows that, under these assumptions, the benefit may justify the cost in Brazil. Treatment is intensive (up to five visits a week for two months) and may not be covered by your insurer. If you are considering it, ask which evidence applies to your situation and what it will cost you.
Note: Talk to your physician before you start a new treatment. Hyperbaric oxygen is not part of standard fibromyalgia guidelines.
